Medicare Part D Basics and Policy Options for Redesign - June 14, 2021
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Participating in the Webinar To mute yourself, click the microphone icon. The icon will appear orange when muted. To ask a question, click the ? icon and enter your question in the chat box below.
Learn More Additional resources available online » • Full speaker bios • Resources list • Expert list • Presentation slides • Recording www.allhealthpolicy.org
Panelists Leigh Purivs, MPA Juliette Cubanski, Ph.D. Director Deputy Director Health Care Costs and Access Program on Medicare Policy AARP Kaiser Family Foundation @leighdrugwonk @jcubanski Moderator Stacie B. Dusetzina, Ph.D. Sarah Dash, MPH Associate Professor of Health Policy President & CEO Vanderbilt University School of Alliance for Health Policy Medicine @DusetzinaS @SarahJDash
INTRODUCTION TO MEDICARE PART D Leigh Purvis, Director, Health Care Costs & Access AARP Public Policy Institute
QUICK BACKGROUND • Created by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 and implemented in 2006 • Provides voluntary outpatient prescription drug coverage (with a late-enrollment penalty) • Includes a Part D Low-Income Subsidy (“Extra Help”) program that helps with premiums and cost-sharing for enrollees with limited incomes and assets AARP PUBLIC POLICY INSTITUTE | AARP.ORG/PPI © 2021 AARP ALL RIGHTS RESERVED June 16, 2021 9
HOW DOES PART D COVERAGE WORK? • Provided through stand-alone prescription drug plans (PDPs) and Medicare Advantage prescription drug plans (MA-PDs) that include drug coverage and other Medicare-covered benefits • Plans must meet defined requirements but can vary in terms of premiums, deductibles, cost-sharing, formularies, utilization management, and pharmacy network AARP PUBLIC POLICY INSTITUTE | AARP.ORG/PPI © 2021 AARP ALL RIGHTS RESERVED June 16, 2021 10
PLAN AVAILABILITY AND ENROLLMENT • Average Medicare beneficiary has a choice of nearly 60 Medicare Part D plans in 2021 (30 PDPs and 27 MA-PDs) • Half of all Part D enrollees are enrolled in stand-alone PDPs and the other half are in MA-PDs, with a slightly larger number of enrollees in MA-PDs • Enrollment is highly concentrated: the top 5 plan sponsors account for 74% of Part D enrollment • Roughly one in four enrollees (~13 million) are in the Part D Low-Income Subsidy (LIS) program AARP PUBLIC POLICY INSTITUTE | AARP.ORG/PPI © 2021 AARP ALL RIGHTS RESERVED June 16, 2021 11
PREMIUMS AND COST-SHARING CAN ADD UP • Average monthly premium charged by PDPs and MA-PDs (weighted by enrollment) has fluctuated recently and is now $26 • However, average masks sizable premium increases among some plans with high enrollment • Enrollees can also face substantial cost-sharing for certain drugs • Maximum cost-sharing for non-preferred drugs is $100 (copay) and 50% (coinsurance) AARP PUBLIC POLICY INSTITUTE | AARP.ORG/PPI © 2021 AARP ALL RIGHTS RESERVED June 16, 2021 12
IS PART D A SUCCESS STORY? • Nearly 90% of older adults have prescription drug coverage • The vast majority of Medicare beneficiaries report high satisfaction with Part D • Perhaps a little bit too satisfied; they aren’t switching plans even when it would benefit them AARP PUBLIC POLICY INSTITUTE | AARP.ORG/PPI © 2021 AARP ALL RIGHTS RESERVED June 16, 2021 13
WILL THE HONEYMOON CONTINUE? • Recent trends could have serious health and financial implications for enrollees who are not in a position to absorb increased costs • Most Medicare beneficiaries live on modest incomes and resources • Median income is just under $30,000 • 1 in 4 have less than $8,500 in savings AARP PUBLIC POLICY INSTITUTE | AARP.ORG/PPI © 2021 AARP ALL RIGHTS RESERVED June 16, 2021 14
@jcubanski Juliette Cubanski, Ph.D. Deputy Director Program on Medicare Policy Kaiser Family Foundation
Medicare Part D Basics Alliance for Health Reform June 16, 2021 Juliette Cubanski, PhD, MPP, MPH Deputy Director, Program on Medicare Policy, KFF @jcubanski
Figure 17 Medicare Part D Standard Benefit Design in 2021 Share of costs paid by: Enrollees Plans Medicare Manufacturers 5% Catastrophic $12,000 coverage phase $11,000 15% 80% $10,048 total / $10,000 $6,550 out of pocket $9,000 $8,000 Coverage gap phase $7,000 25% 70% 5% $6,000 $5,000 $4,000 $4,130 Initial coverage $3,000 phase $2,000 25% 75% $1,000 100% $445 Deductible $0
Figure 18 Medicare Part D standard benefit parameters have increased over time Total drug spending at catastrophic threshold $10,048 Out-of-pocket threshold for catastrophic coverage Initial coverage limit Deductible $6,550 $5,100 $4,130 $3,600 $2,250 $250 $445 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2020 NOTE: Where applicable, estimates are rounded to nearest whole dollar. SOURCE: KFF, based on Part D benefit parameters, 2006-2021.
Figure 19 Most Part D enrollees have relatively low out-of-pocket drug costs, but a small share pay thousands of dollars out of pocket each year Average Out-of-Pocket Spending by Medicare Part D Enrollees in 2018 $3,135 $487 $72 Enrollees receiving Enrollees not receiving Enrollees with out-of-pocket low-income subsidies low-income subsidies spending above the catastrophic threshold Number of enrollees: 13.9 million 32.2 million 1.1 million SOURCE: KFF analysis of a 20% sample of 2018 Medicare prescription drug event claims from the CMS Chronic Conditions Data Warehouse.
Figure 20 Overall Medicare Part D spending has increased over time, and spending will continue to grow in the future $200 Total Part D Spending (in billions): Actual Projected $190 $178 $180 $167 $160 $157 $146 $138 $140 $129 $121 $120 $102 $112 $105 $98 $100 $90 $93 $94 $82 $80 $66 $69 $73 $54 $58 $63 $60 $50 $44 $40 $20 $0 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 SOURCE: 2016-2020 Annual Report of the Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds, Table IV.B10.
Figure 21 Spending for catastrophic coverage (“reinsurance”) now accounts for close to half of total Medicare Part D spending, up from 14% in 2006 Reinsurance Direct Premiums Low-income Retiree drug subsidy subsidy subsidy $102.3 $92.7 $94.4 $97.5 1% $89.6 $81.8 29% $72.9 $66.0 $68.5 $62.5 $57.9 14% $53.9 $50.3 $44.3 14% 9% 34% 8% 45% 8% 14% 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 SOURCE: 2016-2020 Annual Report of the Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds, Table IV.B10.
Figure 22 Since 2015, at least 1 million Medicare Part D enrollees have had out- of-pocket spending above the catastrophic coverage threshold 1,118,945 1,002,700 1,016,580 1,016,660 891,720 681,860 516,580 483,640 407,240 424,260 397,680 380,380 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 NOTE: Estimates exclude enrollees who receive low-income subsidies. SOURCE: KFF analysis of 2007-2018 prescription drug claims data from the CMS Chronic Conditions Data Warehouse.
Figure 23 After a period of relatively slow growth, average Medicare Part D enrollee costs are projected to increase at a faster rate in the coming decade 2006-2010 2010-2019 2019-2029 (projected) 2006-2010 2010-2019 2019-2029 (projected) 6.0% 5.5% 5.0% 3.7% 4.0% 3.0% 2.0% 2.0% 1.0% 0.0% SOURCE: KFF analysis of Medicare spending data from the 2020 Annual Report of the Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds, Table V.D1.
@DusetzinaS Stacie B. Dusetzina, Ph.D. Associate Professor of Health Policy Vanderbilt University School of Medicine
Options for Medicare Part D Redesign Stacie B. Dusetzina, PhD Associate Professor of Health Policy Ingram Associate Professor of Cancer Research Vanderbilt University School of Medicine
Reform Proposals • S.2543 – The Prescription Drug Pricing Reduction Act of 2019 (Senate Finance Bill) • H.R. 3 – the Elijah E. Cummings Lower Drug Costs Now Act • H.R. 19 – the Lower Costs, More Cures Act of 2021 26
Benefit Today 27
Redesign Proposals – General Overview • Eliminates the coverage gap. • New out-of-pocket limit for patients. • Plans are responsible for 75% of spending between the deductible and out-of-pocket limit. • Plans and manufacturers face higher spending after the out-of-pocket limit; Medicare reinsurance is lowered from 80% to 20%. 28
Simplified Benefit Under Redesign Plans 75% Plan 60% Manufacturer 20% Patients 25% Medicare 20% Brand Spending < $10,045 Initial Coverage Phase Catastrophic Coverage Phase 29
Differences by Bills Previously Introduced Medicare Part D coverage phase H.R. 3 S. 2543 H.R. 19 Patient: 25% Patient: 20% Patient: 15% Plan: 65% Plan: 73% Plan: 75% Initial coverage Manufacturer: 10% Manufacturer: 7% Manufacturer: 10% Patient: 0% Patient: 0% Patient: 0% Medicare: 20% Medicare: 20% Medicare: 20% Plan: 50% Plan: 66% Plan: 70% Catastrophic coverage Manufacturer: 30% Manufacturer: 14% Manufacturer: 10% Out-of-pocket limit $2,000 $3,100 $3,100 Source: https://www.commonwealthfund.org/publications/explainer/2021/may/medicare-part-d- redesign 30
Bottom Line • Medicare Part D redesign bills agree on key details: • Simplify the benefit for patients; • Cap out-of-pocket spending; • Lower Medicare reinsurance spending. • Small differences in the percentage paid by manufacturers or plans by phase across bills. • Manufacturer contributions range from 7%-10% in the initial phase and from 10% to 30% in the catastrophic phase. • Plan contributions range from 65% to 75% in the initial phase and 50% to 70% in the catastrophic phase. 31
We value your input! Please fill out the evaluation survey you will receive immediately after this presentation, or via email this afternoon! www.allhealthpolicy.org
Upcoming Events Sept. 2021 Signature Series: Health Equity A detailed agenda will be available on our website soon. 15-16 Coming Soon… Alliance’s Health Policy Handbook This Handbook features a collection of six chapters, each offering a basic introduction to core health policy topics such as provider rates, coverage, drug pricing, and more. www.allhealthpolicy.org
Learn More Additional resources available online » • Full speaker bios • Resources list • Expert list • Presentation slides • Recording www.allhealthpolicy.org
Thank you for attending.
You can also read